|
MDx is evolving — and so is our annual conference!
Once a rare and exclusive form of testing, molecular diagnostics is now growing so rapidly, it’s more crucial than ever to have insight into what’s happening now—and what’s next.
With this in mind, all of us at G2 Intelligence invite you to join us in Boston, April 17-19, for our 7th annual event, as we unveil a whole new focus: MDx NEXT.
Practical conference sessions oriented toward labs of all sizes will tackle key questions and hot topics in molecular diagnostics, including:
- As molecular markets get increasingly crowded, what are the best testing opportunities, how should they be priced, and do they make financial sense for your laboratory?
- How can laboratories best build and optimize their molecular test menus?
- With the wave of molecular diagnostics-based partnerships involving diagnostics companies and major pharmaceutical players, where do hospital labs fit in?
- How are pharmacogenomics and personalized medicine affecting the interaction of clinical labs and physician practices?
- What are the leading risks and challenges you should be aware of in the next two to three years in this market?
Cutting-edge content. Esteemed expert faculty. Invaluable networking opportunities. Find out what attendees are saying and who attends G2’s preeminent gathering of molecular and genetics experts and business leaders representing the nation’s top molecular laboratories.
We hope to see you at the Fairmont Copley Plaza in Boston this spring!
Three Easy Ways to Register for MDx NEXT 2012 Spring
For more information on MDx NEXT 2012, including multi-attendee discounts for your organization, please contact Jeff Watkins at +1.973.718.4709 or email jwatkins@G2Intelligence.com. |
Gold Sponsor:
Silver Sponsors:
|